Transport and the Order Parameter of Superconducting UPt3

We calculate the ultrasonic absorption and the thermal conductivity in the superconducting state of UPt$_{3}$ as functions of temperature and direction of propagation and polarization. Two leading candidates for the superconducting order parameter are considered: the $E_{1g}$ and $E_{2u}$ representations. Both can fit the data except for the ultrasonic absorption in the $A$ phase. To do that, it is necessary to suppose that the system has only a single domain, and that must be chosen as the most favorable one. However, the $E_{2u}$ theory requires fine-tuning of parameters to fit the low temperature thermal conductivity. Thus, transport data favor the $E_{1g}$ theory. Measurements of the thermal conductivity as a function of pressure at low temperature could help to further distinguish the two theories.Comment: 7 pages, 4 figure

Thermal conductivity in B- and C- phase of UPt_3

Although the superconductivity in UPt_3 is one of the most well studied, there are still lingering questions about the nodal directions in the B and C phase in the presence of a magnetic field. Limiting ourselves to the low temperature regime (T<<Delta(0)), we study the magnetothermal conductivity with in semiclassical approximation using Volovik's approach. The angular dependence of the magnetothermal conductivity for an arbitrary field direction should clarify the nodal structure in UPt_3.Comment: 4 pages, 5 figure

Bromelain protease F9 reduces the CD44 mediated adhesion of human peripheral blood lymphocytes to human umbilical vein endothelial cells

AbstractThe thiol protease bromelain has been shown to remove T-cell CD44 molecules from lymphocytes and to affect T-cell activation. We investigated the effect of a highly purified bromelain protease F9 (F9) on the adhesion of peripheral blood lymphocytes (PBL) to human umbilical vein endothelial cells (HUVEC). Preincubation of the lymphocytes with F9 reduced the adherence to about 20% of unstimulated and to about 30% of phorboldibutyrate (P(Bu)2) stimulated lymphocytes. Using flow cytometry, both crude bromelain and protease F9 reduced the expression of CD44, but not of LFA-1, on PBL. F9 was about 10 times more active than crude bromelain; at 2.5 μg/ml of F9 about 97% inhibition of CD44 expression was found. A mAb against CD44 was tested and found to block the F9-induced decrease in PBL-binding to HUVEC. The results indicate that F9 selectively decreases the CD44 mediated binding of PBL to HUVEC